137 related articles for article (PubMed ID: 37268784)
1. Randomized, Placebo-Controlled, Multicenter Clinical Study on the Efficacy and Safety of Lidocaine Patches in Chinese Patients with Postherpetic Neuralgia.
Wang A; Li H; Xie Z; Li L; Jiang X; Guo Q; Hu F; Zhang J; Cui Y; Ding Y; Fang H; Han X; Guo S; Wang J; Ni N
Dermatol Ther (Heidelb); 2023 Jul; 13(7):1477-1487. PubMed ID: 37268784
[TBL] [Abstract][Full Text] [Related]
2. A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Pregabalin for Postherpetic Neuralgia in a Population of Chinese Patients.
Liu Q; Chen H; Xi L; Hong Z; He L; Fu Y; Fang H; Shang N; Yan P; Fan D
Pain Pract; 2017 Jan; 17(1):62-69. PubMed ID: 26714731
[TBL] [Abstract][Full Text] [Related]
3. Topical lidocaine for the treatment of postherpetic neuralgia.
Khaliq W; Alam S; Puri N
Cochrane Database Syst Rev; 2007 Apr; (2):CD004846. PubMed ID: 17443559
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of lidocaine patch 5% to treat herpes zoster acute neuralgia and to prevent postherpetic neuralgia.
Bianchi L; Piergiovanni C; Marietti R; Renzini M; Gori F; Hansel K; Tramontana M; Stingeni L
Dermatol Ther; 2021 Jan; 34(1):e14590. PubMed ID: 33244838
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of piroxicam patch compared to lidocaine patch for the treatment of postherpetic neuralgia.
Kim JY; Lim HJ; Lee WJ; Lee SJ; Kim DW; Kim BS
Ann Dermatol; 2011 May; 23(2):162-9. PubMed ID: 21747614
[TBL] [Abstract][Full Text] [Related]
7. 5% lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in France.
Clère F; Delorme-Morin C; George B; Navez M; Rioult B; Tiberghien-Chatelain F; Ganry H
Drugs Aging; 2011 Sep; 28(9):693-702. PubMed ID: 21913735
[TBL] [Abstract][Full Text] [Related]
8. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia.
Davies PS; Galer BS
Drugs; 2004; 64(9):937-47. PubMed ID: 15101784
[TBL] [Abstract][Full Text] [Related]
9. The Treatment of Topical Drugs for Postherpetic Neuralgia: A Network Meta-Analysis.
Liu X; Wei L; Zeng Q; Lin K; Zhang J
Pain Physician; 2020 Nov; 23(6):541-551. PubMed ID: 33185370
[TBL] [Abstract][Full Text] [Related]
10. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study.
Galer BS; Rowbotham MC; Perander J; Friedman E
Pain; 1999 Apr; 80(3):533-538. PubMed ID: 10342414
[TBL] [Abstract][Full Text] [Related]
11. Clinical Efficacy of Pulsed Radiofrequency Combined with Intravenous Lidocaine Infusion in the Treatment of Subacute Herpes Zoster Neuralgia.
Zhang W; He C
Pain Res Manag; 2022; 2022():5299753. PubMed ID: 35450055
[TBL] [Abstract][Full Text] [Related]
12. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.
Binder A; Bruxelle J; Rogers P; Hans G; Bösl I; Baron R
Clin Drug Investig; 2009; 29(6):393-408. PubMed ID: 19432499
[TBL] [Abstract][Full Text] [Related]
13. Fulranumab in Patients With Pain Associated With Postherpetic Neuralgia and Postraumatic Neuropathy: Efficacy, Safety, and Tolerability Results From a Randomized, Double-blind, Placebo-controlled, Phase-2 Study.
Wang H; Romano G; Fedgchin M; Russell L; Sanga P; Kelly KM; Frustaci ME; Thipphawong J
Clin J Pain; 2017 Feb; 33(2):99-108. PubMed ID: 27153360
[TBL] [Abstract][Full Text] [Related]
14. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
Loncharich MF; Anderson CW
ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a metered-dose 8% lidocaine pump spray for patients with post-herpetic neuralgia.
Kanai A; Kumaki C; Niki Y; Suzuki A; Tazawa T; Okamoto H
Pain Med; 2009; 10(5):902-9. PubMed ID: 19682274
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
[TBL] [Abstract][Full Text] [Related]
17. Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Rauck RL; Irving GA; Wallace MS; Vanhove GF; Sweeney M
J Pain Symptom Manage; 2013 Aug; 46(2):219-28. PubMed ID: 23149085
[TBL] [Abstract][Full Text] [Related]
18. Long-term safety and efficacy of mirogabalin in Asian patients with postherpetic neuralgia: Results from an open-label extension of a multicenter randomized, double-blind, placebo-controlled trial.
Kato J; Matsui N; Kakehi Y; Murayama E; Ohwada S
Medicine (Baltimore); 2020 Sep; 99(36):e21976. PubMed ID: 32899037
[TBL] [Abstract][Full Text] [Related]
19. Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial.
Katz NP; Gammaitoni AR; Davis MW; Dworkin RH;
Pain Med; 2002 Dec; 3(4):324-32. PubMed ID: 15099237
[TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
